PreprintPDF Available

Timing and contents of early palliative care preferred by patients with advanced cancer in Japan: an Internet-based questionnaire survey

Authors:
Preprints and early-stage research may not have been peer reviewed yet.

Abstract

Purpose To clarify the preferred timing and contents of early palliative care and preference for continued care delivery among patients with advanced cancer in Japan. Methods We conducted an Internet-based anonymous questionnaire survey on adult patients with advanced cancer. We assessed the patients’ wishes for palliative care delivered by a team or at outpatient clinics while asymptomatic, as well as the preferred intervention timing and preference for continuing care lifelong. Palliative care contents, cancer status, understanding and goals of cancer treatment, symptoms, and background factors were compared among these three preferences. Results In total, 531 patients responded (mean age, 61 years; men, 70%; major primary cancer sites, urological tract and breast), of whom 345 patients (65%) wished for palliative care while asymptomatic, and multivariate analysis revealed that a desire to address daily living and financial issues; wishing for consultations regarding illness, treatment, and end-of-life care; young age; primary sites other than hematological or urological sites; and increased physical distress were significantly associated with this wish. Approximately 51.3% of patients preferred palliative care before completing cancer treatment, while 40% preferred continuing palliative care lifelong. Young patients preferred early palliative care, and patients with a desire to address social distress preferred continuing palliative care. Conclusion The results highlight the importance of early palliative care planning in patients with advanced cancer; however, evaluating the eligibility for palliative care is essential.
Page 1/10
Timing and contents of early palliative care
preferred by patients with advanced cancer in
Japan: an Internet-based questionnaire survey
Hitoya Sano
Gifu Welfare Federation of Agricultural Cooperatives, Gifu Seino Medical Center, Seino Kosei Hospita
Takuya Odagiri
Gifu Welfare Federation of Agricultural Cooperatives, Gifu Seino Medical Center, Seino Kosei Hospita
Keisuke Tagami
Yamato Home Care Clinic Tome
Yu Uneno
Kyoto University
Manabu Muto
Kyoto University
Research Article
Keywords: early palliative care, advanced cancer, internet survey, younger age, social distress
Posted Date: June 17th, 2024
DOI: https://doi.org/10.21203/rs.3.rs-4521040/v1
License: This work is licensed under a Creative Commons Attribution 4.0 International License. 
Read Full License
Additional Declarations: No competing interests reported.
Page 2/10
Abstract
Purpose
To clarify the preferred timing and contents of early palliative care and preference for continued care
delivery among patients with advanced cancer in Japan.
Methods
We conducted an Internet-based anonymous questionnaire survey on adult patients with advanced
cancer. We assessed the patients’ wishes for palliative care delivered by a team or at outpatient clinics
while asymptomatic, as well as the preferred intervention timing and preference for continuing care
lifelong. Palliative care contents, cancer status, understanding and goals of cancer treatment,
symptoms, and background factors were compared among these three preferences.
Results
In total, 531 patients responded (mean age, 61 years; men, 70%; major primary cancer sites, urological
tract and breast), of whom 345 patients (65%) wished for palliative care while asymptomatic, and
multivariate analysis revealed that a desire to address daily living and nancial issues; wishing for
consultations regarding illness, treatment, and end-of-life care; young age; primary sites other than
hematological or urological sites; and increased physical distress were signicantly associated with this
wish. Approximately 51.3% of patients preferred palliative care before completing cancer treatment,
while 40% preferred continuing palliative care lifelong. Young patients preferred early palliative care, and
patients with a desire to address social distress preferred continuing palliative care.
Conclusion
The results highlight the importance of early palliative care planning in patients with advanced cancer;
however, evaluating the eligibility for palliative care is essential.
Background and Objectives
Palliative care for advanced cancer has been recommended not only at the end-of-life stage but also at
an early stage, such as when the disease is conrmed to be incurable [1]. Palliative care during early
stages has been shown to have positive effects on the quality of life, depression, and survival of patients
[2–4]. Based on these reports, the American Society of Cancer Oncology recommends that palliative
care should be initiated during the cancer treatment phase [19].
Page 3/10
Some studies have compared two types of early palliative care interventions [6, 7]: one involves
intervening at a certain stage of the disease, and the other is to intervene on-demand when patients
become symptomatic. Various proposals for initiating palliative care interventions exist [8]. A study
conducted in the United States investigated the appropriateness of the timing of palliative care
interventions [18] and reported that outpatient supportive care clinic referral was perceived by most
patients as timely and useful, and a low symptom burden was associated with the perception of being
referred early.
In Japan, the 2012 Basic Law on Cancer Control recommends “promotion of palliative care from the time
of advanced cancer diagnosis” [20]. However, no studies have investigated the preferences of patients
with advanced cancer for early palliative care. Our previous study was conducted among bereaved
families of patients with cancers who died in palliative care units [9]. Thus, early palliative care from a
patient's perspective is not fully understood.
The primary aim of this study was to determine the timing and contents of early palliative care preferred
by patients with advanced cancer in Japan. The secondary aim was to explore preferences of patients
for continuing palliative care.
Methods
This was an Internet-based anonymous questionnaire survey conducted in February 2023. Participants
provided consent using the opt-in consent method. The study was reviewed and approved by the ethics
committees of Kyoto University Graduate School and Faculty of Medicine, Kyoto University Hospital, in
compliance with Ethical Guidelines for Medical and Biological Research Involving Human Subjects in
Japan (approval number: R3810). Because this study was a questionnaire survey, with no invasive
interventions, of patients who voluntarily enrolled, no risks or disadvantages were anticipated. The study
was conducted by a private contractor, and the researchers did not collect any personal information
about the patients. The study was conducted in compliance with the Declaration of Helsinki and Ethical
Guidelines for Medical Research Involving Human Subjects and initiated after the research protocol was
approved by the ethics committees of all institutions to which the researchers belonged. An introductory
page was created, ample opportunity for refusal was provided, and a response was considered consent.
Subjects
The survey included adult patients with advanced cancer who were registered anonymously on the web
panel of the Japanese online research company Macromill Inc. (Tokyo, Japan). Macromill Inc. was
selected because of the ensured quality of procedures enabling inclusion of patients with advanced
cancer nationwide. To recruit respondents, e-mails were sent to 5,000 candidates, of whom 500 passed
the screening questionnaire assessment to identify suitable respondents. The screening questionnaire
included questions such as whether the participants had cancer and whether the cancer was either
locally advanced or metastasized. Patients with no recurrence or metastasis, under 18 years of age, and
who were unable to respond online were excluded.
Page 4/10
Survey items
The parameters assessed in the survey were the following.
1. Patients’ preference for interventions by the palliative care team or at outpatient palliative care
clinics while asymptomatic
The preferred timing was selected from the following [9]: when the disease was conrmed incurable or
recurrent, during treatment or follow-up, when treatment became ineffective or the disease worsened, or
when they became unable to take care of themselves.
2. Patients’ preference for the continuation of palliative care
This was selected as continuation until the end of life or temporary.
3. Patients’ preference for the contents of palliative care interventions
This was selected based on the following items using a 5-point scale (1, not desired; 5, desired): dealing
with physical distress, dealing with mental distress, dealing with families’ distress, addressing daily life
and nancial issues, consultation regarding illness and treatment, consultation regarding terminal care,
and counseling for meaning of life.
4. Cancer status
Cancer treatment status (i.e., undergoing cancer treatment or follow-up, cancer treatment completed,
etc.), length of time since the diagnosis of recurrence or metastasis, prior palliative care interventions,
and Eastern Cooperative Oncology Group performance status were assessed.
5. Patients’ understanding of cured status and goals of cancer treatment [11]
Patients’ understanding of cancer as cured or cured by treatment was assessed using a 4-point scale
ranging from 1 (highly likely) to 4 (not at all likely). Patients’ understanding of the goals of cancer
treatment were selected from the following: relieving distress, maintaining hope, ensuring that all
treatments have been completed, prolonging life as long as possible, curing cancer, helping cancer
research, etc.
. Patients’ current symptoms
The symptoms were assessed according to the Integrated Palliative Care Outcome Scale-Japanese
Version (IPOS-j [10]; score range, 0 [not at all] to 4 [overwhelming]) and included physical distress, mental
distress, social distress, and spiritual pain.
7. Patients’ background factors
Page 5/10
Factors, including age, sex, primary site, area of residence, highest educational qualication, profession,
personal and family income, cohabitator details, marital status, details of children, and religious beliefs,
were assessed.
Statistical analysis
As the primary outcome, we calculated the frequency distribution of item a. Subsequently, we compared
items c to g using univariate analysis (i.e., Welch’s test or Fisher’s exact test) according to the wish to
undergo palliative care, and items with a
p
-value < 0.200 in the univariate analysis were compared using
multiple logistic regression analysis.
Next, in patients who wished to undergo palliative care, we compared items c to g according to the
preferred intervention timing in the same manner as mentioned above. Since no difference was observed
in the univariate results among the four intervention timings(i.e.,when the disease was conrmed
incurable or recurrent, during treatment or follow-up, when treatment became ineffective or the disease
worsened, or when they became unable to take care of themselves)and two intervention timings (i.e.,
before and after completing anticancer treatment), we compared the items using the latter timings.
In addition, as the secondary outcome, we calculated the frequency distribution of item b. We also
compared items c to g using the same univariate and multivariate analyses according to the preference
for continuing palliative care. All analyses were performed using SPSS 19.1 (IBM Japan, Tokyo, Japan); a
p
-value < 0.05 was considered signicant, and missing values were not analyzed.
Results
Five hundred and thirty-one adult patients with advanced cancer responded to the survey (average age,
61.2 years; men, 70.8%; major primary sites, urological tract and breast), and 98.3% of them were
undergoing cancer treatment or follow-up. In addition, 116 patients (21.8%) indicated that they had
received palliative care interventions (Table1).
Of the 531 patients, 345 (65.0%) wished to undergo palliative care team/outpatient interventions while
asymptomatic. Items signicantly associated with considering palliative care interventions were a desire
to address daily living and nancial issues; consultations regarding illness, treatment, and end-of-life
care; young age; primary sites other than hematological or urological sites; and increased physical
distress (Table2).
Of the 345 patients who wished to undergo palliative care, 74 (21.4%) preferred interventions when the
disease was conrmed incurable or recurrent, 103 (29.9%) preferred interventions during treatment or
follow-up, 123 (35.7%) preferred interventions when treatment became ineffective or the disease
progressed, and 45(13.0%) preferred interventions when they became unable to take care of themselves.
In the multivariate analysis, young age was signicantly associated with the preferred time of
intervention before completing cancer treatment (Table3).
Page 6/10
Regarding the preference for continuing palliative care, 205 (39.9%) of the 514 (17 with missing data)
patients wished to continue palliative care until the end of life, whereas 309 (60.1%) preferred temporary
palliative care. In the multivariate analysis, the items signicantly associated with considering continuing
palliative care until the end of life were a desire to address daily life and nancial issues, believing less
that treatment would cure the disease, and having treatment goals other than prolonging life or curing
cancer (Table4).
Discussion
To the best of our knowledge, this is the rst study in Japan on preferences for timing, content, and
continuing palliative care based on a survey of patients themselves. The most important result was that
65.0% of patients wished to undergo palliative care while asymptomatic, and 51.3% of them wished to
undergo interventions before completing cancer treatment. However, palliative care interventions were
provided to only 21.8% of patients in this study. In our previous study [9], in which we surveyed bereaved
families of cancer patients, 32.3% of patients received palliative care during cancer treatment, and a
large percentage of patients’ relatives judged the timing of palliative care referral as appropriate
compared with the families of patients who received palliative care after cancer treatment, and
appropriateness of timing and good quality of death were signicantly associated. The present study
also suggests that the timing of palliative care interventions should be earlier. However, not everyone
requires palliative care; therefore, evaluating the eligibility of patients is essential.
The next important result was concerning the items related to wishing for palliative care interventions
while asymptomatic: a wish to address daily living and nancial issues; consultations regarding illness,
treatment, and end-of-life care; young age; and increased physical distress. However, if the primary sites
were hematological or urological, the patients did not request palliative care interventions. Young age
was also associated with wishing for palliative care before completing cancer treatment. According to
the 2018 patient experience survey report by the National Cancer Center’s Cancer Control and
Information Center [16], young patients had disadvantages in terms of nances, employment status,
building relationships, and dialogue with healthcare providers, indicating that they had higher care needs
than older patients, consistent with the present results. Although palliative care has conventionally
focused on the palliation of physical and psychological distress, a strong wish to address social distress
and undergo early palliative care interventions seems to exist among young patients. In the present
study, another request for palliative care was related to consultations regarding illness and treatment,
which was reported in the classic early palliative care study by Temel et al. [12] as well. The importance
of advanced care planning in palliative care has also been noted [17], as suggested by the present study.
In contrast, patients with hematological and urological cancers did not wish to receive palliative care.
Hematological cancers may be treated even in advanced disease states, and palliative care interventions
tend to be delayed [13, 14]. Patients with urological cancers are relatively old [15], and they may have
less preference for early palliative care.
Page 7/10
Another important result of this study was that 39.9% of patients preferred continuing palliative care until
the end of life. This preference was associated with a desire to address social problems and a lack of
motivation for undergoing cancer treatment. Since social problems can persist over the entire trajectory
of an illness, patients with social problems may wish to continue palliative care.
The present study had some limitations. First, although this study included patients with advanced
cancer, the advanced cancer status was conrmed only by self-reporting. Second, we recruited only
patients registered with a private monitoring provider, which might have introduced a background bias.
As shown in Table1, data for all regions, cancer sites, and income levels were obtained. However, the
average age of the patients is 61 years, which is less than that of all patients with cancer, possibly
because of the Internet-based responses. Young age was associated with a preference for early
palliative care, and fewer early palliative care seekers may have resulted if all age groups were included.
In the present study, a large proportion of patients wished for early palliative care compared with the
previous study on bereaved families [9]. Finally, most of the patients were undergoing cancer treatment
or follow-up (Table1). Palliative care preferences differ among patients who cannot be treated for
cancer. Therefore, clarifying the preferences of such patients who are targets of early palliative care is
essential.
Conclusion
In the present study conducted in Japan, approximately 2/3rd of patients with advanced cancer preferred
palliative care interventions while asymptomatic, and half of them wished to undergo palliative care
before completing cancer treatment. Forty percent of patients wished to continue palliative care until the
end of life. Young patients wished to undergo early palliative care, whereas those who wished to address
social distress preferred to continue palliative care.
Declarations
Competing interests
The authors have no conicts of interest.
Ethics approval
This study was conducted in compliance with the Declaration of Helsinki and Ethical Guidelines for
Medical and Biological Research Involving Human Subjects in Japan and approved by the ethics
committees of Kyoto University Graduate School and Faculty of Medicine, Kyoto University Hospital
(approval number: R3810).
Consent to participate
Page 8/10
Participants provided consent using the opt-in consent method.
Consent to publish
All authors agree to publish this article.
Funding
This work was supported by the Ministry of Health, Labor, and Welfare of Japan (Health Labor Science
Research Grant, Grant No. 20EA1009). The funder had no role in the conception and/or design of the
work; the acquisition, analysis, and interpretation of data; and/or the drafting of this manuscript.
Author Contribution
All authors contributed to the study conception and design. Material preparation and data collection
were performed by Yu Ueno. Analysis and the rst draft of the manuscript were performed by Hitoya
Sano and Takuya Odagiri. All authors commented on previous versions of the manuscript. All authors
read and approved the nal manuscript.
Acknowledgement
This work was supported by the Ministry of Health, Labor, and Welfare of Japan (Health Labor Science
Research Grant, Grant No. 20EA1009). We would like to thank Editage (www.editage.jp) for English
language editing.
References
1. . Temel JS, Greer JA, Muzikansky A et al (2010) Early palliative care for patients with metastatic non-
small-cell lung cancer. N Engl J Med 363(8):733–742. https://doi.org/10.1056/NEJMoa1000678
2. . Huo B, Song Y, Chang L, Tan B (2022) Effects of early palliative care on patients with incurable
cancer: a meta-analysis and systematic review. Eur J Cancer Care (Engl) 31(6):e13620.
https://doi.org/10.1111/ecc.13620
3. . Haun MW, Estel S, Rücker, et al (2017) Early palliative care for adults with advanced cancer.
Cochrane Database Syst Rev 6(6):CD011129. https://doi.org/10.1002/14651858.CD011129.pub2
4. . Gaertner J, Siemens W, Meerpohl JJ et al (2017) Effect of specialist palliative care services on
quality of life in adults with advanced incurable illness in hospital, hospice, or community settings:
systematic review and meta-analysis. BMJ 357:j2925. https://doi.org/10.1136/bmj.j2925
5. . Ferrell BR, Temel JS, Temin S et al (2017) Integration of palliative care into standard oncology care:
American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35(1):96–112.
Page 9/10
https://doi.org/10.1200/JCO.2016.70.1474
. . Maltoni M, Scarpi E, Dall’Agata M et al (2016) Systematic versus on-demand early palliative care:
results from a multicentre, randomised clinical trial. Eur J Cancer 65:61–68.
https://doi.org/10.1016/j.ejca.2016.06.007
7. . Scarpi E, Dall’Agata M, Zagonel V et al (2019) Systematic vs. on-demand early palliative care in
gastric cancer patients: a randomized clinical trial assessing patient and healthcare service
outcomes. Support Care Cancer 27(7):2425–2434. https://doi.org/10.1007/s00520-018-4517-2
. . Kayastha N, LeBlanc TW (2020) When to integrate palliative care in the trajectory of cancer care.
Curr Treat Options Oncol 21(5):41. https://doi.org/10.1007/s11864-020-00743-x
9. . Tagami K, Masukawa K, Inoue A, et al (2022) Appropriate referral timing to specialized palliative
care service: survey of bereaved families of cancer patients who died in palliative care units.
Support Care Cancer 30(1):931–940. https://doi.org/10.1007/s00520-021-06493-2
10. . Sakurai H, Miyashita M, Imai K et al (2019) Validation of the Integrated Palliative care Outcome
Scale (IPOS) – Japanese Version. Jpn J Clin Oncol, Japanese version 49(3):257–262.
https://doi.org/10.1093/jjco/hyy203
11. . Janssens A, Derijcke S, Lefebure A et al (2017) Addressing the palliative setting in advanced lung
cancer should not remain a barrier: a multicenter study. Clin Lung Can 18(4):e283–e287.
https://doi.org/10.1016/j.cllc.2017.01.001
12. . Greer JA, Pirl WF, Jackson VA et al (2012) Effect of early palliative care on chemotherapy use and
end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol 30(4):394–400.
https://doi.org/10.1200/JCO.2011.35.7996
13. . Moreno-Alonso D, Porta-Sales J, Monforte-Royo C et al (2018) Palliative care in patients with
haematological neoplasms: an integrative systematic review. Palliat Med 32(1):79–105.
https://doi.org/10.1177/0269216317735246
14. . Howell DA, Shellens R, Roman E et al (2011) Haematological malignancy: are patients appropriately
referred for specialist palliative and hospice care? A systematic review and meta-analysis of
published data. Palliat Med 25(6):630–641. https://doi.org/10.1177/0269216310391692
15. . Raghavan D, Skinner E (2004) Genitourinary cancer in the elderly. Semin Oncol 31(2):249–263.
https://doi.org/10.1053/j.seminoncol.2003.12.034
1. . https://www.mhlw.go.jp/content/10901000/00860132.pdf Accessed Aug 30, 2023
17. . Bischoff K, O’Riordan DL, Marks AK, Sudore R, Pantilat SZ (2018) Care planning for inpatients
referred for palliative care consultation. JAMA Intern Med 178(1):48–54.
https://doi.org/10.1001/jamainternmed.2017.6313
1. . Wong A, Vidal M, Prado B et al (2019) Patients’ perspective of timeliness and usefulness of an
outpatient supportive care referral at a comprehensive cancer center. J Pain Symptom Manage
58(2):275–281. https://doi.org/10.1016/j.jpainsymman.2019.04.027
19. Ferrell BR, Temel JS, Temin S, et al (2024) Integration of palliative care into standard oncology care:
American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35(1):96–112.
Page 10/10
https://doi.org/10.1200/JCO.2016.70.1474
20. Cancer Control Act (in Japanese). https://www.mhlw.go.jp/le/06-Seisakujouhou-10900000-
Kenkoukyoku/gan_keikaku02.pdf
Tables
Tables 1-4 is available in the Supplementary Files section.
Supplementary Files
This is a list of supplementary les associated with this preprint. Click to download.
Table.xlsx
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Few studies have investigated appropriate referral timing of specialized palliative care (SPC) from the perspective of cancer patients’ and families’ experiences. We aimed to clarify appropriate SPC referral timing for patients with advanced cancer and their families. We used data from a nationwide bereaved family survey in Japan. We sent a questionnaire to 999 bereaved families of cancer patients who died in 164 palliative care units (PCUs) and analyzed the first SPC referral timing and how patients evaluated it. We defined SPC as outpatient or inpatient palliative care service comprising certified palliative care physicians, advanced-practice nurses, and multidisciplinary practitioners. Finally, 51.6% (n = 515) of all responses were analyzed. The SPC referral timing was evaluated as appropriate (26.1%), late or too late (20.2%), early or too early (1.2%), or none of these (52.5%). Of these, 32.3% reported that they were referred to an SPC when diagnosed with advanced or incurable cancer or during anti-cancer treatment, and 62.6% reported they were referred after anti-cancer treatment. Patient-perceived appropriateness of SPC referral timing was associated with their good death process. After excluding “none of these” responses, a significantly higher proportion of respondents who reported being referred to SPC at diagnosis and during anti-cancer treatment evaluated the response timing as appropriate, compared to those who reported being referred after anti-cancer treatment. Appropriate timing for SPC referrals relates to quality of death; findings suggest that appropriate timing is at the time of diagnosis or during anti-cancer treatment.
Article
Full-text available
Opinion statement: Palliative care provides an extra layer of support to patients and families facing a serious illness. To date, several studies support the use of early, integrated palliative care for patients with cancer, based upon documented improvements in quality of life, symptoms, mood, satisfaction, utilization, and even overall survival. Despite this, patients with cancer continue to have unmet palliative care needs, and palliative care services are often engaged late in their care, if at all. Amid this under-utilization, questions remain about the optimal timing and nature of palliative care integration. To answer this question, we briefly review the evidence based for palliative care in oncology, and discuss three approaches to optimizing the timing of palliative care integration: (1) prognosis-based, (2) needs-based, and (3) trigger-based models. Prognosis-based models most closely mirror the approach of randomized trials to date, but are overly dependent on prognostication, and may miss patients with unmet needs who do not meet standard definitions of poor-prognosis disease. Needs-based models may better capture patients in a personalized manner, based on actual needs, but require sophisticated screening systems to be integrated into routine care processes, along with clinician buy-in. This may lead to excessive referrals, which strain the already limited palliative care workforce. As such, a blended, trigger-based approach may be best, allowing one to utilize certain disease-based and prognosis-based triggers for referral, plus screening of unmet needs, to identify those patients most likely to benefit from integrated palliative care when they need it most.
Article
Full-text available
Purpose Early palliative care (EPC) has shown a positive impact on quality of life (QoL), quality of care, and healthcare costs. We evaluated such effects in patients with advanced gastric cancer. Methods In this prospective, multicenter study, 186 advanced gastric cancer patients were randomized 1:1 to receive standard cancer care (SCC) plus on-demand EPC (standard arm) or SCC plus systematic EPC (interventional arm). Primary outcome was a change in QoL between randomization (T0) and T1 (12 weeks after T0) in the Trial Outcome Index (TOI) scores evaluated through the Functional Assessment of Cancer Therapy-Gastric questionnaire. Secondary outcomes were patient mood, overall survival, and family satisfaction with healthcare and care aggressiveness. Results The mean change in TOI scores from T0 to T1 was − 1.30 (standard deviation (SD) 20.01) for standard arm patients and 1.65 (SD 22.38) for the interventional group, with a difference of 2.95 (95% CI − 4.43 to 10.32) (p = 0.430). The change in mean Gastric Cancer Subscale values for the standard arm was 0.91 (SD 14.14) and 3.19 (SD 15.25) for the interventional group, with a difference of 2.29 (95% CI − 2.80 to 7.38) (p = 0.375). Forty-three percent of patients in the standard arm received EPC. Conclusions Our results indicated a slight, albeit not significant, benefit from EPC. Findings on EPC studies may be underestimated in the event of suboptimally managed issues: type of intervention, shared decision-making process between oncologists and PC physicians, risk of standard arm contamination, study duration, timeliness of assessment of primary outcomes, timeliness of cohort inception, and recruitment of patients with a significant symptom burden. Clinical trial registration ClinicalTrials.gov (NCT01996540).
Article
Full-text available
Importance Care planning is a critical function of palliative care teams, but the impact of advance care planning and goals of care discussions by palliative care teams has not been well characterized. Objective To describe the population of patients referred to inpatient palliative care consultation teams for care planning, the needs identified by palliative care clinicians, the care planning activities that occur, and the results of these activities. Design, Setting, and Participants This was a prospective cohort study conducted between January 1, 2013, and December 31, 2016. Seventy-eight inpatient palliative care teams from diverse US hospitals in the Palliative Care Quality Network, a national quality improvement collaborative. Standardized data were submitted for 78 145 patients. Exposures Inpatient palliative care consultation. Results Overall, 52 571 of 73 145 patients (71.9%) referred to inpatient palliative care were referred for care planning (range among teams, 27.5%-99.4% of patients). Patients referred for care planning were older (73.3 vs 67.9 years; F statistic, 1546.0; P < .001), less likely to have cancer (30.0% vs 41.1%; P < .001), and slightly more often had a clinical order of full code at the time of referral (54.6% vs 52.1%; P < .001). Palliative care teams identified care planning needs in 52 825 of 73 145 patients (72.2%) overall, including 42 467 of 49 713 patients (85.4%) referred for care planning and in 10 054 of 17 475 patients (57.5%) referred for other reasons. Through care planning conversations, surrogates were identified for 10 571 of 11 149 patients (94.8%) and 9026 patients (37.4%) elected to change their code status. Substantially more patients indicated that a status of do not resuscitate/do not intubate was consistent with their goals (7006 [32.1%] preconsultation to 13 773 [63.1%] postconsultation). However, an advance directive was completed for just 2160 of 67 955 patients (3.2%) and a Physicians Orders for Life-Sustaining Treatment form was completed for 8359 of 67 955 patients (12.3%) seen by palliative care teams. Conclusions and Relevance Care planning was the most common reason for inpatient palliative care consultation, and care planning needs were often found even when the consultation was for other reasons. Surrogates were consistently identified, and patients’ preferences regarding life-sustaining treatments were frequently updated. However, a minority of patients completed legal forms to document their care preferences, highlighting an area in need of improvement.
Article
Full-text available
Background Palliative care was originally intended for patients with non-haematological neoplasms and relatively few studies have assessed palliative care in patients with haematological malignancies. Aim To assess palliative care interventions in managing haematological malignancies patients treated by onco-haematology departments. Design Integrative systematic review with data extraction and narrative synthesis (PROSPERO #: CRD42016036240). Data sources PubMed, CINAHL, Cochrane, Scopus and Web-of-Science were searched for articles published through 30 June 2015. Study inclusion criteria were as follows: (1) published in English or Spanish and (2) containing data on palliative care interventions in adults with haematological malignancies. Results The search yielded 418 articles; 99 met the inclusion criteria. Six themes were identified: (1) end-of-life care, (2) the relationship between onco-haematology and palliative care departments and referral characteristics, (3) clinical characteristics, (4) experience of patients/families, (5) home care and (6) other themes grouped together as ‘miscellany’. Our findings indicate that palliative care is often limited to the end-of-life phase, with late referral to palliative care. The symptom burden in haematological malignancies patients is more than the burden in non-haematological neoplasms patients. Patients and families are generally satisfied with palliative care. Home care is seldom used. Tools to predict survival in this patient population are lacking. Conclusion Despite a growing interest in palliative care for haematological malignancies patients, the evidence base needs to be strengthened to expand our knowledge about palliative care in this patient group. The results of this review support the need to develop closer cooperation and communication between the palliative care and onco-haematology departments to improve patient care.
Article
Full-text available
Objective To assess the effect of specialist palliative care on quality of life and additional outcomes relevant to patients in those with advanced illness. Design Systematic review with meta-analysis. Data sources Medline, Embase, Cochrane Central Register of Controlled Trials, PsycINFO, and trial registers searched up to July 2016. Eligibility criteria for selecting studies Randomised controlled trials with adult inpatients or outpatients treated in hospital, hospice, or community settings with any advanced illness. Minimum requirements for specialist palliative care included the multiprofessional team approach. Two reviewers independently screened and extracted data, assessed the risk of bias (Cochrane risk of bias tool), and evaluated the quality of evidence (GRADE tool). Data synthesis Primary outcome was quality of life with Hedges’ g as standardised mean difference (SMD) and random effects model in meta-analysis. In addition, the pooled SMDs of the analyses of quality of life were re-expressed on the global health/QoL scale (item 29 and 30, respectively) of the European Organization for Research and Treatment of Cancer QLQ-C30 (0-100, high values=good quality of life, minimal clinically important difference 8.1). Results Of 3967 publications, 12 were included (10 randomised controlled trials with 2454 patients randomised, of whom 72% (n=1766) had cancer). In no trial was integration of specialist palliative care triggered according to patients’ needs as identified by screening. Overall, there was a small effect in favour of specialist palliative care (SMD 0.16, 95% confidence interval 0.01 to 0.31; QLQ-C30 global health/QoL 4.1, 0.3 to 8.2; n=1218, six trials). Sensitivity analysis showed an SMD of 0.57 (−0.02 to 1.15; global health/QoL 14.6, −0.5 to 29.4; n=1385, seven trials). The effect was marginally larger for patients with cancer (0.20, 0.01 to 0.38; global health/QoL 5.1, 0.3 to 9.7; n=828, five trials) and especially for those who received specialist palliative care early (0.33, 0.05 to 0.61, global health/QoL 8.5, 1.3 to 15.6; n=388, two trials). The results for pain and other secondary outcomes were inconclusive. Some methodological problems (such as lack of blinding) reduced the strength of the evidence. Conclusions Specialist palliative care was associated with a small effect on QoL and might have most pronounced effects for patients with cancer who received such care early. It could be most effective if it is provided early and if it identifies though screening those patients with unmet needs. Systematic review registration PROSPERO CRD42015020674.
Article
Objective: This meta-analysis aims to compare the effects of early palliative care on patients with incurable cancer with those of standard oncologic care or on-demand palliative care. Methods: Pubmed, Embase, Web of Science, Cochrane Library, ClinicalTrials.gov and World Health Organization International Clinical Trials Registry Platform (ICTRP) were searched for relevant randomised controlled trials. We also screened reference lists of included studies for additional qualified studies. We used Cochrane Collaboration Risk of Bias Tool to evaluate quality of included studies. DerSimonian and Laird's random effects meta-analysis was used to synthesise the effects. Results: Sixteen in 1376 studies were included. The pooled data suggested that patients receiving early palliative care had better quality of life (SMD = 0.737, 95% CI: 0.240-1.234), fewer symptoms (SMD = 0.304, 95% CI: 0.097-0.510), better mood (SMD = -0.443, 95% CI: -0.605 to -0.282), better survival (hazard ratio [HR] of death: HR = 1.521, 95% CI: 1.521-1.923; 1-year overall survival probability: HR = 1.238, 95% CI: 1.031-1.486) and higher probability of dying at home (HR = 1.153, 95% CI: 1.027-1.295) than patients in the control group. And there is no difference between resource use. Conclusion: Early palliative care improves lives of patients with incurable cancer, but the evidence level is low because of high heterogeneity of quality of life and small numbers of included studies for other results.
Article
Context: Current guidelines recommend early referral to palliative care for patients with advanced cancer; however, no studies have examined the optimal timing of referral from the patients' perspective. Objectives: To examine patients' perceptions of timeliness of referral and its association with survival among patients with advanced cancer referred to an outpatient supportive care (SC) clinic. Methods: This cross-sectional prospective study in an SC clinic at a comprehensive cancer center included patients aged 18 years or older with locally advanced, recurrent, or metastatic cancer. Patients were asked to complete an anonymous survey regarding the timeliness and perceived usefulness of SC referral within four weeks of their first SC consultation. Results: Of 253 eligible patients, 209 (83%) enrolled in the study and 200 completed the survey. Median survival was 10.3 months. Most patients (72%) perceived that referral occurred "just in time," whereas 21% felt it was "late," and 7% felt "early." A majority (83%) found the referral useful, and 88% would recommend it to other patients with cancer. The perception of being referred early was associated with lower reported levels of pain (P = 0.043), fatigue (P = 0.004), drowsiness (P = 0.005), appetite loss (P = 0.041), poor well-being (P = 0.041), and lower physical (P = 0.001) and overall symptom distress (P = 0.001). No other associations were found between perceived timeliness and usefulness and patients' baseline characteristics. Conclusion: Most patients with a median survival of 10 months perceived that SC referral was timely and useful. Patient care needs rather than the timing of advanced cancer diagnosis drove this perception of referral timing. Lower symptom burden was associated with the perception of being referred to early.
Article
Background: To improve palliative care practice, the need for patients-reported outcome measures is increasing globally. The Integrated Palliative care Outcome Scale (IPOS) is a streamlined outcome scale developed to comprehensively evaluate patients' distress. The goal of this study is to assess the reliability and validity of IPOS-Japanese version in cancer patients. Methods: This is a multicenter, cross-sectional observational study. We assessed the missing values, prevalence, test-retest reliability, criterion validity and known-group validity in Japanese adult cancer patients. Patients provided responses to IPOS, European Organization for Research and Treatment for Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30), and Functional Assessment of Chronic Illness Therapy- Spiritual 12 (FACIT-Sp12). Our medical staff provided responses to Support Team Assessment Schedule (STAS). Results: One hundred forty-two patients were enrolled at six palliative care facilities. Missing values accounted for less than 1% of most items, with a maximum of 2.8%. The prevalence of symptoms was 17.7-88.7%. The intra-class correlation coefficient ranged from 0.522 to 0.951. The range of correlation coefficients with EORTC-QLQ-C30, FACIT-Sp12 and STAS as gold standards was 0.013 to 0.864 (absolute values). Total IPOS scores were positively correlated with Eastern Corporative Oncology Group Performance Status (P < 0.001). Conclusion: IPOS-Japanese version is a valid and reliable tool. The scale is useful in assessing physical, psychological, social and spiritual symptoms and in measuring outcomes of adult cancer patients in Japan.
Article
Background: Incurable cancer, which often constitutes an enormous challenge for patients, their families, and medical professionals, profoundly affects the patient's physical and psychosocial well-being. In standard cancer care, palliative measures generally are initiated when it is evident that disease-modifying treatments have been unsuccessful, no treatments can be offered, or death is anticipated. In contrast, early palliative care is initiated much earlier in the disease trajectory and closer to the diagnosis of incurable cancer. Objectives: To compare effects of early palliative care interventions versus treatment as usual/standard cancer care on health-related quality of life, depression, symptom intensity, and survival among adults with a diagnosis of advanced cancer. Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycINFO, OpenGrey (a database for grey literature), and three clinical trial registers to October 2016. We checked reference lists, searched citations, and contacted study authors to identify additional studies. Selection criteria: Randomised controlled trials (RCTs) and cluster-randomised controlled trials (cRCTs) on professional palliative care services that provided or co-ordinated comprehensive care for adults at early advanced stages of cancer. Data collection and analysis: We used standard methodological procedures as expected by Cochrane. We assessed risk of bias, extracted data, and collected information on adverse events. For quantitative synthesis, we combined respective results on our primary outcomes of health-related quality of life, survival (death hazard ratio), depression, and symptom intensity across studies in meta-analyses using an inverse variance random-effects model. We expressed pooled effects as standardised mean differences (SMDs, or Hedges' adjusted g). We assessed certainty of evidence at the outcome level using GRADE (Grading of Recommendations Assessment, Development, and Evaluation) and created a 'Summary of findings' table. Main results: We included seven randomised and cluster-randomised controlled trials that together recruited 1614 participants. Four studies evaluated interventions delivered by specialised palliative care teams, and the remaining studies assessed models of co-ordinated care. Overall, risk of bias at the study level was mostly low, apart from possible selection bias in three studies and attrition bias in one study, along with insufficient information on blinding of participants and outcome assessment in six studies.Compared with usual/standard cancer care alone, early palliative care significantly improved health-related quality of life at a small effect size (SMD 0.27, 95% confidence interval (CI) 0.15 to 0.38; participants analysed at post treatment = 1028; evidence of low certainty). As re-expressed in natural units (absolute change in Functional Assessment of Cancer Therapy-General (FACT-G) score), health-related quality of life scores increased on average by 4.59 (95% CI 2.55 to 6.46) points more among participants given early palliative care than among control participants. Data on survival, available from four studies enrolling a total of 800 participants, did not indicate differences in efficacy (death hazard ratio 0.85, 95% CI 0.56 to 1.28; evidence of very low certainty). Levels of depressive symptoms among those receiving early palliative care did not differ significantly from levels among those receiving usual/standard cancer care (five studies; SMD -0.11, 95% CI -0.26 to 0.03; participants analysed at post treatment = 762; evidence of very low certainty). Results from seven studies that analysed 1054 participants post treatment suggest a small effect for significantly lower symptom intensity in early palliative care compared with the control condition (SMD -0.23, 95% CI -0.35 to -0.10; evidence of low certainty). The type of model used to provide early palliative care did not affect study results. One RCT reported potential adverse events of early palliative care, such as a higher percentage of participants with severe scores for pain and poor appetite; the remaining six studies did not report adverse events in study publications. For these six studies, principal investigators stated upon request that they had not observed any adverse events. Authors' conclusions: This systematic review of a small number of trials indicates that early palliative care interventions may have more beneficial effects on quality of life and symptom intensity among patients with advanced cancer than among those given usual/standard cancer care alone. Although we found only small effect sizes, these may be clinically relevant at an advanced disease stage with limited prognosis, at which time further decline in quality of life is very common. At this point, effects on mortality and depression are uncertain. We have to interpret current results with caution owing to very low to low certainty of current evidence and between-study differences regarding participant populations, interventions, and methods. Additional research now under way will present a clearer picture of the effect and specific indication of early palliative care. Upcoming results from several ongoing studies (N = 20) and studies awaiting assessment (N = 10) may increase the certainty of study results and may lead to improved decision making. In perspective, early palliative care is a newly emerging field, and well-conducted studies are needed to explicitly describe the components of early palliative care and control treatments, after blinding of participants and outcome assessors, and to report on possible adverse events.